Accessibility Menu
 
BioCorRx logo

BioCorRx

(OTC) BICX

Current Price$0.40
Market Cap$10.56M
Since IPO (2011)-87%
5 Year-86%
1 Year+30%
1 Month+0%

BioCorRx Financials at a Glance

Market Cap

$10.56M

Revenue (TTM)

$797.24K

Net Income (TTM)

$3.44M

EPS (TTM)

$-0.32

P/E Ratio

-1.24

Dividend

$0.00

Beta (Volatility)

0.23 (Low)

Price

$0.40

Volume

100

Open

$0.40

Previous Close

$0.40

Daily Range

$0.40 - $0.40

52-Week Range

$0.20 - $0.50

BICX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioCorRx

Industry

Healthcare Providers and Services

CEO

Lourdes Felix, MBA

Headquarters

Anaheim, CA 92806, US

BICX Financials

Key Financial Metrics (TTM)

Gross Margin

87%

Operating Margin

-6%

Net Income Margin

-4%

Return on Equity

0%

Return on Capital

78%

Return on Assets

-2%

Earnings Yield

-80.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.56M

Shares Outstanding

26.40M

Volume

100

Avg. Volume

2.95K

Financials (TTM)

Gross Profit

$691.38K

Operating Income

$4.83M

EBITDA

$2.56M

Operating Cash Flow

$2.30M

Capital Expenditure

$0.00

Free Cash Flow

$2.30M

Cash & ST Invst.

$139.36K

Total Debt

$2.13M

BioCorRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$151.12K

-342.4%

Gross Profit

$173.82K

+535.9%

Gross Margin

-1.15%

N/A

Market Cap

$10.56M

N/A

Market Cap/Employee

$3.52M

N/A

Employees

3

N/A

Net Income

$552.55K

+147.4%

EBITDA

$398.01K

+54.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.99M

+26.8%

Accounts Receivable

$253.46K

N/A

Inventory

$143.43K

N/A

Long Term Debt

$185.28K

-19.5%

Short Term Debt

$1.94M

-24.6%

Return on Assets

-1.60%

N/A

Return on Invested Capital

78.45%

N/A

Free Cash Flow

$847.72K

-243.0%

Operating Cash Flow

$847.72K

-243.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCLOFPharmaCielo Ltd.
$0.05+30.21%
FAMDFFutura Medical plc
$0.03+200.00%
XCRTXcelerate Inc.
$0.02+1.52%
HLYKHealthLynked Corp.
$2.85+8.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About BICX

What is the current price of BioCorRx?

BioCorRx is trading at $0.40 per share.

What is the 52-week range for BioCorRx?

Over the past 52 weeks, BioCorRx has traded between $0.20 and $0.50.

How much debt does BioCorRx have?

As of the most recent reporting period, BioCorRx reported total debt of $7.75M.

How much cash does BioCorRx have on hand?

BioCorRx reported $287,688 in cash and cash equivalents in its most recent financial results.

What is BioCorRx’s dividend yield?

BioCorRx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.